20 March 2018
Tilray has signed a binding letter of intent (LoI) with Sandoz Canada to advance the development and commercialisation of medical cannabis products in the country.
27 February 2018
Manufacturing solutions provider ACG group has signed a memorandum of understanding (MoU) with secure molecular technologies firm Applied DNA Sciences for the development of molecularly tagged empty hard-shell capsules.
17 January 2018
Sun Pharmaceutical Industries’ wholly owned subsidiaries have reached an agreement with Ironwood Pharmaceuticals and Allergan to resolve the patent litigation associated with the submission of an abbreviated new drug application...
3 January 2018
US-based ANI Pharmaceuticals has purchased the rights from AstraZeneca to market Atacand, Atacand HCT, Arimidex and Casodex tablets in the country.
6 June 2017
Canadian research-based pharmaceutical firm Purdue Pharma has entered a distribution and licence agreement to distribute, promote, market and sell Swiss pharmaceutical group Helsinn’s Aloxi (palonosetron hydrochloride) in the country.
5 June 2017
Danish-based Veloxis Pharmaceuticals’ US subsidiary has signed two different exclusive licence, supply and distribution agreements to register, commercialise and distribute Envarsus XR in China, Taiwan and Canada.
23 May 2017
Sanofi and Regeneron Pharmaceuticals’ drug Kevzara (sarilumab) has received the US Food and Drug Administration (FDA) approval to treat adult patients affected with moderately to severely active rheumatoid arthritis (RA).
21 May 2017
Merck’s Isentress (raltegravir) 600mg film-coated tablets have received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), for the treatment...
17 May 2017
Singapore-based biopharmaceutical company Specialised Therapeutics Asia (ST Asia) will commercialise a new anti-cancer compound known as lurbinectedin (PM1183) throughout South East Asia, following a second major licensing deal with Spanish...
16 May 2017
Biopharmaceutical company Cytokinetics’ CK-2127107 has received orphan drug designation from the Office of Orphan Products Development of the US Food and Drug Administration (FDA) for the potential treatment of spinal...